Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

ECCO 15 - ESMO 34

The Second Opinion Panel - a programme allowing Danish patients to receive specialist treatment abroad

Prof Heine Hansen - The Finsen Institute, Copenhagen, Denmark

The Second Opinion Panel - a programme allowing Danish patients to receive specialist treatment abroad ( Prof Heine Hansen - The Finsen Institute, Copenhagen, Denmark )

The latest advances in radiation oncology

Prof Michael Baumann - Medical Faculty Carl Gustav Carus, University of Technology, Dresden, Germany

The latest advances in radiation oncology ( Prof Michael Baumann - Medical Faculty Carl Gustav Carus, University of Technology, Dresden, Germany )

Prioritisation in cancer research

Prof Richard Sullivan - King's College, London, UK

Prioritisation in cancer research ( Prof Richard Sullivan - King's College, London, UK )

PET in the treatment of Hodgkin's Lymphoma

Dr Lena Specht - Copenhagen University Hospital

PET in the treatment of Hodgkin's Lymphoma ( Dr Lena Specht - Copenhagen University Hospital )

Triple negative breast cancer

Dr Susanne Briest - University of Leipzig, Germany

Triple negative breast cancer ( Dr Susanne Briest - University of Leipzig, Germany )

The problems of getting new molecules to the clinic

Prof Mariano Barbacid - Spanish National Cancer Centre, Madrid

The problems of getting new molecules to the clinic ( Prof Mariano Barbacid - Spanish National Cancer Centre, Madrid )

Current situation with aromatase inhibitors

Prof Charles Coombes - Imperial College School of Medicine, London, UK

Current situation with aromatase inhibitors ( Prof Charles Coombes - Imperial College School of Medicine, London, UK )

European Association for Cancer Research

Prof Anne-Lise Borresen-Dale - President of the European Association for Cancer Research

European Association for Cancer Research ( Prof Anne-Lise Borresen-Dale - President of the European Association for Cancer Research )

Young people with cancer

Dr Jeremy Whelan - University College London

Young people with cancer ( Dr Jeremy Whelan - University College London )

Epidemiology of colorectal cancer and surgical treatment

Dr Gabriela Moeslein - St Josef's Hospital, Bochum-Linden, Germany

Epidemiology of colorectal cancer and surgical treatment ( Dr Gabriela Moeslein - St Josef's Hospital, Bochum-Linden, Germany )

European action against rare cancers

Dr Paolo Casali - Executive Commitee Member, European Society for Medical Oncology

European action against rare cancers ( Dr Paolo Casali - Executive Commitee Member, European Society for Medical Oncology )

Cryopreservation of ovarian tissue

Prof Jacques Donnez - Catholic University of Louvain, Brussels, Belgium

Cryopreservation of ovarian tissue ( Prof Jacques Donnez - Catholic University of Louvain, Brussels, Belgium )

ECCO 15 - ESMO 34 Conference

Prof José Baselga - President of ESMO

ECCO 15 - ESMO 34 Conference ( Prof José Baselga - President of ESMO )

Potential prognostic value of isolated tumour cells in breast cancer sentinel nodes

Dr Marjut Leidenius - Breast Surgery Unit, Helsinki University Central Hospital

Potential prognostic value of isolated tumour cells in breast cancer sentinel nodes ( Dr Marjut Leidenius - Breast Surgery Unit, Helsinki University Central Hospital )

Circulating tumour cells

Anieta Sieuwerts - Erasmus University Rotterdam

Circulating tumour cells ( Anieta Sieuwerts - Erasmus University Rotterdam )

Patient perspective of ECCO 15 - ESMO 34

Jan Geissler - Director, European Cancer Patient Coalition

Patient perspective of ECCO 15 - ESMO 34 ( Jan Geissler - Director, European Cancer Patient Coalition )

Guidelines for safer handling of cytotoxics

Dr Klaus Meier - President of the European Society of Oncology Pharmacy

Guidelines for safer handling of cytotoxics ( Dr Klaus Meier - President of the European Society of Oncology Pharmacy )

Breast cancer screening in older women

Prof Silvio Monfardini - Azienda Ospedaliera di Padova, Italy

Breast cancer screening in older women ( Prof Silvio Monfardini - Azienda Ospedaliera di Padova, Italy )

ECCO-ESMO Patient advocacy symposium conclusions

Sandra Craine - Chronic Myeloid Leukaemia Support Group, UK

ECCO-ESMO Patient advocacy symposium conclusions ( Sandra Craine - Chronic Myeloid Leukaemia Support Group, UK )

Costs of licensing clinical trials

Prof. John Smyth - Assistant Principal Cancer Research Development, University of Edinburgh

Costs of licensing clinical trials ( Prof. John Smyth - Assistant Principal Cancer Research Development, University of Edinburgh )

Importance of exchanging scientific information

Prof Jean-Yves Blay - University Claude Bernard, Lyon, France

Importance of exchanging scientific information ( Prof Jean-Yves Blay - University Claude Bernard, Lyon, France )

European Action Against Rare Cancers

Kathy Oliver - International Brain Tumour Alliance

European Action Against Rare Cancers ( Kathy Oliver - International Brain Tumour Alliance )

Increasing prostate cancer awareness

Tom Hudson - Chair of Europa Uomo

Increasing prostate cancer awareness ( Tom Hudson - Chair of Europa Uomo )

Hyper-reactions to radiotherapy

Dirk De Ruysscher - University Hospital Maastricht, Netherlands

Hyper-reactions to radiotherapy ( Dirk De Ruysscher - University Hospital Maastricht, Netherlands )

Early detection of cancer

Prof. Ron Laskey - University of Cambridge

Early detection of cancer ( Prof. Ron Laskey - University of Cambridge )

Targeted agents in the treatment of advanced NSCLC

Prof Johan Vansteenkiste - Leuven University Hospital, Belgium

Targeted agents in the treatment of advanced NSCLC ( Prof Johan Vansteenkiste - Leuven University Hospital, Belgium )

Round table discussion on targeted therapies for metastatic breast cancer

Prof McVie discusses the issues with breast cancer experts

Round table discussion on targeted therapies for metastatic breast cancer ( Prof McVie discusses the issues with breast cancer experts )

Compounds to improve disease control in advanced breast cancer

Dr Peyman Hadji - Head of the Department of Endocrinology, Osteoporosis and Reproductive Medicine at Philipps-University of Marburg, Germany

Compounds to improve disease control in advanced breast cancer ( Dr Peyman Hadji - Head of the Department of Endocrinology, Osteoporosis and Reproductive Medicine at Philipps-University of Marburg, Germany )

Consultant Breast and Endocrine Surgeon, Western Infirmary, Glasgow, Scotland.

Dr Julie Doughty

Consultant Breast and Endocrine Surgeon, Western Infirmary, Glasgow, Scotland. ( Dr Julie Doughty )

DNA damage, oncogene activation and chromatin

Dr Fabrizio d'Adda di Fagagna - Principal Investigator, IFOM-IEO, Milan, Italy

DNA damage, oncogene activation and chromatin ( Dr Fabrizio d'Adda di Fagagna - Principal Investigator, IFOM-IEO, Milan, Italy )

New targeted drugs for metastatic renal cell carcinoma

Dr Joaquim Bellmunt - Section Chief, Solid Tumor Oncology, Hospital del Mar, Barcelona, Spain

New targeted drugs for metastatic renal cell carcinoma ( Dr Joaquim Bellmunt - Section Chief, Solid Tumor Oncology, Hospital del Mar, Barcelona, Spain )

A new era of melanoma treatment

Prof Alexander Eggermont - President of the European CanCer Organisation

A new era of melanoma treatment ( Prof Alexander Eggermont - President of the European CanCer Organisation )

Vaccination and testing for the human papilloma virus could eradicate cervical cancer

Prof Jack Cuzick - Head of Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, London

Vaccination and testing for the human papilloma virus could eradicate cervical cancer ( Prof Jack Cuzick - Head of Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, London )

Excess body weight causes over 124,000 new cancers a year in Europe

Dr Andrew Renehan - University of Manchester, UK

Excess body weight causes over 124,000 new cancers a year in Europe ( Dr Andrew Renehan - University of Manchester, UK )

New insights in staging tools, surgical, and medical management of stage II-III melanoma

Prof Alexander M. M. Eggermont, Erasmus University, Rotterdam, The Netherlands

New insights in staging tools, surgical, and medical management of stage II-III melanoma ( Prof Alexander M. M. Eggermont, Erasmus University, Rotterdam, The Netherlands )

Panel discussion and final conclusions

New approaches in advanced melanoma

Panel discussion and final conclusions ( New approaches in advanced melanoma )

ANTI-CTLA-4: A new immunological approach

Dr Jeff Weber, Moffitt Cancer Center, Tampa, Florida, USA

ANTI-CTLA-4: A new immunological approach ( Dr Jeff Weber, Moffitt Cancer Center, Tampa, Florida, USA )

ECCO 15 - ESMO 34 News 23rd September 2009

Prof Gordon McVie - ecancer Managing Editor

ECCO 15 - ESMO 34 News 23rd September 2009 ( Prof Gordon McVie - ecancer Managing Editor )

Current Challenges in the Treatment of Advanced Melanoma

Prof Axel Hauschild - University of Kiel, Germany

Current Challenges in the Treatment of Advanced Melanoma ( Prof Axel Hauschild - University of Kiel, Germany )

Two treatments for advanced melanoma show significant improvements in overall survival

Dr Paul Chapman - Memorial Sloan-Kettering Cancer Center, USA

Two treatments for advanced melanoma show significant improvements in overall survival ( Dr Paul Chapman - Memorial Sloan-Kettering Cancer Center, USA )

New cancer research priorities to correct imbalance that leaves important questions neglected

Prof Richard Sullivan - King's College, London

New cancer research priorities to correct imbalance that leaves important questions neglected ( Prof Richard Sullivan - King's College, London )

ECCO 15 - ESMO 34 News 22nd September 2009

Prof Gordon McVie - ecancer Managing Editor

ECCO 15 - ESMO 34 News 22nd September 2009 ( Prof Gordon McVie - ecancer Managing Editor )

Prostate cancer patients on hormone therapy at increased risk for various heart diseases

Ms Mieke Van Hemelrijck - King's College, London

Prostate cancer patients on hormone therapy at increased risk for various heart diseases ( Ms Mieke Van Hemelrijck - King's College, London )

Targeted heat therapy offers new standard treatment option for soft tissue sarcoma

Prof Rolf Issels - University of Munich, Germany

Targeted heat therapy offers new standard treatment option for soft tissue sarcoma ( Prof Rolf Issels - University of Munich, Germany )

The role of EONS, patient interaction and oncology nursing variations by country

Sara Faithfull - President of the European Oncology Nursing Society

The role of EONS, patient interaction and oncology nursing variations by country ( Sara Faithfull - President of the European Oncology Nursing Society )

New European Academy of Cancer Sciences will help shape future oncology policy

Prof Alexander Eggermont - President of the European CanCer Organisation (ECCO)

New European Academy of Cancer Sciences will help shape future oncology policy ( Prof Alexander Eggermont - President of the European CanCer Organisation (ECCO) )

ECCO 15 - ESMO 34 News 20-21 September, 2009

Prof Gordon McVie - ecancer Managing Editor

ECCO 15 - ESMO 34 News 20-21 September, 2009 ( Prof Gordon McVie - ecancer Managing Editor )

Translational research - a contribution to future cancer treatment

Prof Otmar Wiestler - Heidelberg University, Germany

Translational research - a contribution to future cancer treatment ( Prof Otmar Wiestler - Heidelberg University, Germany )

Advanced radiotherapy - the state of art in more precise and individualised cancer treatment

Professor Michael Baumann - Medical Faculty Carl Gustav Carus, University of Technology, Dresden, Germany

Advanced radiotherapy - the state of art in more precise and individualised cancer treatment ( Professor Michael Baumann - Medical Faculty Carl Gustav Carus, University of Technology, Dresden, Germany )

Medical cancer therapy beyond standard chemotherapy

Professor Michael Hallek - Koln University, Germany

Medical cancer therapy beyond standard chemotherapy ( Professor Michael Hallek - Koln University, Germany )

Cancer survivorship: surgery and multimodality treatment for the patient's quality of life

Professor Peter Schlag - University Medicine Berlin, Germany

Cancer survivorship: surgery and multimodality treatment for the patient's quality of life ( Professor Peter Schlag - University Medicine Berlin, Germany )

Aspirin protects against colorectal cancer, says international clinical trial

Professor John Burn, Institute of Human Genetics, Newcastle University, UK

Aspirin protects against colorectal cancer, says international clinical trial ( Professor John Burn, Institute of Human Genetics, Newcastle University, UK )

Surgical removal of primary tumour improves survival in metastatic breast cancer patients

Dr Jetske Ruiterkamp, Jeroen Bosch Hospital, Holland

Surgical removal of primary tumour improves survival in metastatic breast cancer patients ( Dr Jetske Ruiterkamp, Jeroen Bosch Hospital, Holland )

The Oncopolicy Roundtable: ECCO's President and special guests highlight key issues

ECCO 15 - ESMO 34

The Oncopolicy Roundtable: ECCO's President and special guests highlight key issues ( ECCO 15 - ESMO 34 )

ECCO 15 - ESMO 34 Chairs: Why join us in Berlin?

Why attend ECCO 15 - ESMO 34?

ECCO 15 - ESMO 34 Chairs: Why join us in Berlin? ( Why attend ECCO 15 - ESMO 34? )

Highlights and headlines anticipated at the joint ECCO 15 - 34th ESMO Multidisciplinary Congress

Exclusive Preview

Highlights and headlines anticipated at the joint ECCO 15 - 34th ESMO Multidisciplinary Congress ( Exclusive Preview )

More from ecancer